Liminal BioSciences Announces Arrangement Agreement with Structured Alpha LP

Provided By PR Newswire

Last update: Jul 12, 2023

Liminal BioSciences minority shareholders to receive US$8.50 in cash per share in "go private" transaction

LAVAL, QC, CAMBRIDGE, England, and TORONTO, July 12, 2023 /PRNewswire/ - Liminal BioSciences Inc. ("Liminal BioSciences" or the "Company") (NASDAQ: LMNL) and Structured Alpha LP ("SALP"), a fund managed by Thomvest Asset Management Ltd., today announced that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which SALP will acquire all of the issued and outstanding common shares of Liminal BioSciences (the "Common Shares") that it does not already own.